FBB
BSX icon

Fulton Breakefield Broenniman’s Boston Scientific BSX Stock Holding History

Fulton Breakefield Broenniman’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,603
Closed -$226K – 209
2026
Q1 		$226K Buy
+3,603
New +$288K 0.01% 183
2020
Q2 		– Sell
-6,805
Closed -$222K – 166
2020
Q1 		$222K Sell
6,805
-3,990
-37% -$156K 0.03% 142
2019
Q4 		$488K Buy
10,795
+1,745
+19% +$73K 0.06% 118
2019
Q3 		$368K Buy
+9,050
New +$383K 0.05% 125

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fulton Breakefield Broenniman's BSX Position: Q2 2026 in Review

Fulton Breakefield Broenniman sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,603 shares — an estimated $226K sold.

Fulton Breakefield Broenniman first reported a position in BSX in Q3 2019 and held it in 4 quarters. The position peaked at $488K in Q4 2019. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Fulton Breakefield Broenniman reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Fulton Breakefield Broenniman sold 3,603 Boston Scientific shares in Q2 2026, an estimated $226K.
  • Fulton Breakefield Broenniman first reported a position in Boston Scientific in Q3 2019 and held it in 4 quarters.
  • Fulton Breakefield Broenniman's Boston Scientific position peaked at $488K in Q4 2019.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Fulton Breakefield Broenniman's 13F filing for Q2 2026, filed 3 Aug 2026.